SlideShare a Scribd company logo
1 of 12
Analysis of Cellular and
Molecular Factors Influencing
Axonal Degeneration in
Neonatal Mice
Alexis Doggett
Background
Purpose:
Investigate cellular and molecular factors influencing axonal
degeneration, rather than NMJ degeneration, in response to
peripheral nerve injury in mice
WHY?
Neurodegenerative conditions affect millions of people world wide, and
motor neuron degeneration as a widely observed symptom in a subset
of these diseases, the cause of, which is still not fully understood.
Any research done to investigate influences in these disease
processes is critically important for finding cures.
Part 1:
Ex-vivo sciatic nerves from wild type mice over a period of 72 hours
from ages P9-P22
Part II:
Examining protein expression from three proteins implicated in
neurodegenerative processes, in brachial plexus nerves from
wild type mice ages P12- P24
 ROCK2: neuronal survival and stability; actin regulator
 Prp: cellular adhesion, synaptic metabolism, and signal transmission
 SMN: mRNA splicing and axonal transport
Aims and Hypotheses
1. Identify changes in axonal
degeneration by quantifying levels of
WD in neonatal and adult mice.
2. Identify differences in protein
expression from ROCK2, Prp and SMN
across the range in which age-
dependent vulnerability shifts.
3. Discover whether there is a difference
in rate of axonal degeneration between
2B/+ & 2B/- (SMN deficient) mouse
models.
Methods
 Axonal Imagining
◦ Ex-Vivo model with Fluorescent Imaging
◦ Statistical Analysis
 The Axonal Integrity Ratio (AIR) was calculated by dividing the
sum total of fragmented lengths by the total length of the axon.
 Protein Expression Quantification
◦ Western-Blot
◦ LiCOR Scanning
What to look for: Part I
 What is Wallerian Degeneration
(WD)?
◦ Degeneration that appears along the axon
as fragmentation or broken bits
P14 Sciatic Axons at 21 Hours P14 Sciatic Axons at 72 Hours
AIM1: Identify changes in axonal degeneration by
quantifying levels of WD in neonatal and adult mice.
P9 P14 P18 P22
P9
P14
P18
P22
0.0
0.2
0.4
0.6
0.8
Axonal Integrity at 72hrs ExVivo
Age of YFP Wild Type Mice (Postnatal)
AIR(AxonIntegrityRatio)
*
ns
Comparison of AIR between
neonatal and adult mice: (A)
Fluorescent Microscopic images taken
of P9, P14, P18, and P22 Scale Bar:
100μm (B) Average AIR
quantifications from each time point
(P9-P22) compared against each
other, at 72 hours ex-vivo. Statistically
significant difference in degeneration
at 72-hours, between P9 and P22
axons (bars above data sets represent
mean + SEM).
What to look for: Part II
 Changes in Protein Expression
◦ Sample intensity is greater (darker) with
larger protein expression
P12A
10μg 15μg 20μg 30μg
SMN Expression
P12B
AIM 2: Identify differences in protein expression from
ROCK2, Prp and SMN.
P12
P15
P18
P21
P24
0.0
0.5
1.0
1.5
SMN Expression In Brachial Plexus Nerves of Wild Type Mice
Age of Wild Type Mice (Postnatal)
ProteinExpression
P12
P15
P18
P21
P24
Figure 3.2.2. SMN Expression. This figure represents the mean with + SEM of SMN
expression across all five sample ages. Data from this graph was quantified using an
N=2, where P15-24 are normalized to the primary loading of P12. Due to the small N
number the data yielded no statistical significance for any sample sets. A general trend
can be seen where the SMN expression does decrease as age of mice increases.
SMN
α-Tub
P12 P15 P18 P21 P24
AIM 3: Discover whether there is a difference in rate
of axonal degeneration between 2B/+ & 2B/- (SMN
deficient) mouse models.
P18 2B+ at 0 Hrs P18 2B- at 0 Hrs
P18 2B+ at 72 Hrs P18 2B- at 72 Hrs
(A) Fluorescent Microscopy images taken under a green fluorescent channel of P18 2B/+ and 2B/-
Sciatic nerves following dissection and at 72-Hours ex-vivo. Images were taken at 20x
magnification. Scale bar: 100μm. (B) Graph displays differences in AIR quantification between 2B/-
(SMN deficient) and 2B/+ (Control) mouse models. Data was quantified using N=20 axons from 4
nerves of each phenotype. No significant difference noted in degeneration using a Mann-Whitney
analysis, p-value = 0.1292 (bars above data sets represent mean + SEM).
2B
-
2B
+
0.0
0.2
0.4
0.6
0.8
Axonal Integrity of 2B- vs 2B+ mice at 72 hours
Mouse Phenotype
AIR(AxonIntegrityRatio)
ns
A
B
Conclusion
 This project utilized an ex-vivo model to observe
degeneration in neonatal and adult wild type
sciatic nerves
◦ Proved that age-dependent vulnerability does exist in
peripheral nerve axons, similar to that seen within the
NMJ.
 This project also explored potential molecular
mechanisms influencing axonal degeneration
◦ Showed that ROCK2, Prp, and SMN protein
expression all change as age increases.
◦ SMN displayed a trend of decreasing as age of mice
increased
 This project investigated whether levels of SMN
expression effect rates of degeneration
◦ Found that SMN deficient models do not present with
a statistically significant change in axonal
degeneration compared to mice with normal SMN
expression.
Relevance and Future
Studies
 Better understanding of mechanisms that effect
neurodegeneration.
 Investigation into proteins and their exact influence on
motor neurons can lead to potential treatments for
patients suffering from disease.
 Future Studies:
◦ Other disease models and axonal protection
◦ Other protein expression changes over time (i.e.
ApoE, Htt, P-Tau)
Thanks for Listening!
 Any Question?

More Related Content

What's hot

Single-Cell Electrophysiology and 2-Photon Imaging in Awake Mice with 2D-Loco...
Single-Cell Electrophysiology and 2-Photon Imaging in Awake Mice with 2D-Loco...Single-Cell Electrophysiology and 2-Photon Imaging in Awake Mice with 2D-Loco...
Single-Cell Electrophysiology and 2-Photon Imaging in Awake Mice with 2D-Loco...InsideScientific
 
Gene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical DevelopmentGene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical DevelopmentMedpace
 
An update of wallace´s zoogeographic regions of the world
An update of wallace´s zoogeographic regions of the worldAn update of wallace´s zoogeographic regions of the world
An update of wallace´s zoogeographic regions of the worldCarlos Sáenz
 
An Introduction to Crispr Genome Editing
An Introduction to Crispr Genome EditingAn Introduction to Crispr Genome Editing
An Introduction to Crispr Genome EditingChris Thorne
 
Castanon, A-MSc SCRM Poster
Castanon, A-MSc SCRM PosterCastanon, A-MSc SCRM Poster
Castanon, A-MSc SCRM PosterAmaris Castanon
 
Personalized nanomedicine for the treatment of vascular hypertension
Personalized nanomedicine for the treatment of vascular hypertensionPersonalized nanomedicine for the treatment of vascular hypertension
Personalized nanomedicine for the treatment of vascular hypertensionSusanta Kumar Rout
 
Genome Editing Comes of Age
Genome Editing Comes of AgeGenome Editing Comes of Age
Genome Editing Comes of AgeCandy Smellie
 
CRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and HowCRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and HowHorizonDiscovery
 
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MACRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MADiane McKenna
 
Who owns CRISPR? - An update on the Interference.
Who owns CRISPR? - An update on the Interference.Who owns CRISPR? - An update on the Interference.
Who owns CRISPR? - An update on the Interference.Stephen Lieb
 
Cereb. cortex 2009-knafo-586-92
Cereb. cortex 2009-knafo-586-92Cereb. cortex 2009-knafo-586-92
Cereb. cortex 2009-knafo-586-92shiraknafo
 
What happens to_your_brain_on_the_way_to_mars
What happens to_your_brain_on_the_way_to_marsWhat happens to_your_brain_on_the_way_to_mars
What happens to_your_brain_on_the_way_to_marsSérgio Sacani
 
Sigma Xi Powerpoint 2014
Sigma Xi Powerpoint 2014Sigma Xi Powerpoint 2014
Sigma Xi Powerpoint 2014AlliBelette
 
Place Cell Mapping and Stress Monitoring in Head-Fixed Mice Navigating an Air...
Place Cell Mapping and Stress Monitoring in Head-Fixed Mice Navigating an Air...Place Cell Mapping and Stress Monitoring in Head-Fixed Mice Navigating an Air...
Place Cell Mapping and Stress Monitoring in Head-Fixed Mice Navigating an Air...InsideScientific
 
Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...
Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...
Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...InsideScientific
 
Neural dependence poster
Neural dependence posterNeural dependence poster
Neural dependence posterAnkrish Milne
 
Mary Lin Paper
Mary Lin PaperMary Lin Paper
Mary Lin PaperMary Lin
 
Crispr and superbugs
Crispr and superbugsCrispr and superbugs
Crispr and superbugsAmay Redkar
 

What's hot (20)

Stem Cell Research Powerpoint
Stem Cell Research PowerpointStem Cell Research Powerpoint
Stem Cell Research Powerpoint
 
Single-Cell Electrophysiology and 2-Photon Imaging in Awake Mice with 2D-Loco...
Single-Cell Electrophysiology and 2-Photon Imaging in Awake Mice with 2D-Loco...Single-Cell Electrophysiology and 2-Photon Imaging in Awake Mice with 2D-Loco...
Single-Cell Electrophysiology and 2-Photon Imaging in Awake Mice with 2D-Loco...
 
Gene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical DevelopmentGene Editing - Challenges and Future of CRISPR in Clinical Development
Gene Editing - Challenges and Future of CRISPR in Clinical Development
 
nikolakopoulou et al., 2010_final
nikolakopoulou et al., 2010_finalnikolakopoulou et al., 2010_final
nikolakopoulou et al., 2010_final
 
An update of wallace´s zoogeographic regions of the world
An update of wallace´s zoogeographic regions of the worldAn update of wallace´s zoogeographic regions of the world
An update of wallace´s zoogeographic regions of the world
 
An Introduction to Crispr Genome Editing
An Introduction to Crispr Genome EditingAn Introduction to Crispr Genome Editing
An Introduction to Crispr Genome Editing
 
Castanon, A-MSc SCRM Poster
Castanon, A-MSc SCRM PosterCastanon, A-MSc SCRM Poster
Castanon, A-MSc SCRM Poster
 
Personalized nanomedicine for the treatment of vascular hypertension
Personalized nanomedicine for the treatment of vascular hypertensionPersonalized nanomedicine for the treatment of vascular hypertension
Personalized nanomedicine for the treatment of vascular hypertension
 
Genome Editing Comes of Age
Genome Editing Comes of AgeGenome Editing Comes of Age
Genome Editing Comes of Age
 
CRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and HowCRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and How
 
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MACRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
CRISPR Gene Editing Congress, 25-27 February 2015 in Boston, MA
 
Who owns CRISPR? - An update on the Interference.
Who owns CRISPR? - An update on the Interference.Who owns CRISPR? - An update on the Interference.
Who owns CRISPR? - An update on the Interference.
 
Cereb. cortex 2009-knafo-586-92
Cereb. cortex 2009-knafo-586-92Cereb. cortex 2009-knafo-586-92
Cereb. cortex 2009-knafo-586-92
 
What happens to_your_brain_on_the_way_to_mars
What happens to_your_brain_on_the_way_to_marsWhat happens to_your_brain_on_the_way_to_mars
What happens to_your_brain_on_the_way_to_mars
 
Sigma Xi Powerpoint 2014
Sigma Xi Powerpoint 2014Sigma Xi Powerpoint 2014
Sigma Xi Powerpoint 2014
 
Place Cell Mapping and Stress Monitoring in Head-Fixed Mice Navigating an Air...
Place Cell Mapping and Stress Monitoring in Head-Fixed Mice Navigating an Air...Place Cell Mapping and Stress Monitoring in Head-Fixed Mice Navigating an Air...
Place Cell Mapping and Stress Monitoring in Head-Fixed Mice Navigating an Air...
 
Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...
Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...
Cerebral Open Flow Microperfusion (cOFM) for in vivo Cerebral Fluid Sampling ...
 
Neural dependence poster
Neural dependence posterNeural dependence poster
Neural dependence poster
 
Mary Lin Paper
Mary Lin PaperMary Lin Paper
Mary Lin Paper
 
Crispr and superbugs
Crispr and superbugsCrispr and superbugs
Crispr and superbugs
 

Viewers also liked

Viewers also liked (6)

Modelos pedagógicos (1)
Modelos pedagógicos (1)Modelos pedagógicos (1)
Modelos pedagógicos (1)
 
Amr Nabil_CV-2016
Amr Nabil_CV-2016Amr Nabil_CV-2016
Amr Nabil_CV-2016
 
Modelos pedagógicos (1)
Modelos pedagógicos (1)Modelos pedagógicos (1)
Modelos pedagógicos (1)
 
La danza-de-los-cuervos
La danza-de-los-cuervosLa danza-de-los-cuervos
La danza-de-los-cuervos
 
про
пропро
про
 
высотная поясность
высотная поясностьвысотная поясность
высотная поясность
 

Similar to DissertationPresentation

Using Pathway Studio in Neurodegenerative disease
Using Pathway Studio in Neurodegenerative diseaseUsing Pathway Studio in Neurodegenerative disease
Using Pathway Studio in Neurodegenerative diseaseAnn-Marie Roche
 
SfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_ProgranulinSfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_ProgranulinPierre Zwiegers
 
Phenotypic screening using MEAs
Phenotypic screening using MEAsPhenotypic screening using MEAs
Phenotypic screening using MEAsNeuroProof GmbH
 
NKCC1 Poster for SIRS 2010
NKCC1 Poster for SIRS 2010NKCC1 Poster for SIRS 2010
NKCC1 Poster for SIRS 2010lrt5000
 
Insights into the epigenetic mechanisms involving histone lysine
Insights into the epigenetic mechanisms involving histone lysineInsights into the epigenetic mechanisms involving histone lysine
Insights into the epigenetic mechanisms involving histone lysineashutosh mahale
 
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...Manjunath Pujar
 
Monitoring neural activities by optical imaging
Monitoring neural activities by optical imagingMonitoring neural activities by optical imaging
Monitoring neural activities by optical imagingMd Kafiul Islam
 
Mockabee COM scholar poster 032316
Mockabee COM scholar poster 032316Mockabee COM scholar poster 032316
Mockabee COM scholar poster 032316Ryan Mockabee
 
Poster - determining the effects of tau on synaptic density in a mouse model ...
Poster - determining the effects of tau on synaptic density in a mouse model ...Poster - determining the effects of tau on synaptic density in a mouse model ...
Poster - determining the effects of tau on synaptic density in a mouse model ...Shaun Croft, MScR
 
Florence Molinari INMED-INSERM U901. Marseille.
Florence Molinari   INMED-INSERM U901. Marseille. Florence Molinari   INMED-INSERM U901. Marseille.
Florence Molinari INMED-INSERM U901. Marseille. Fundación Ramón Areces
 
Florence Molinari - INMED-INSERM U901. Marseille.
Florence Molinari - INMED-INSERM U901. Marseille. Florence Molinari - INMED-INSERM U901. Marseille.
Florence Molinari - INMED-INSERM U901. Marseille. Fundación Ramón Areces
 
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...HCS Pharma
 
Presentation at the CRS Mtg 2002
Presentation at the CRS Mtg 2002Presentation at the CRS Mtg 2002
Presentation at the CRS Mtg 2002gbalwani
 
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...Manjunath Pujar
 
Positron emission tomographic scan
Positron emission tomographic scanPositron emission tomographic scan
Positron emission tomographic scanPrashant Makhija
 

Similar to DissertationPresentation (20)

Using Pathway Studio in Neurodegenerative disease
Using Pathway Studio in Neurodegenerative diseaseUsing Pathway Studio in Neurodegenerative disease
Using Pathway Studio in Neurodegenerative disease
 
SfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_ProgranulinSfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_Progranulin
 
Phenotypic screening using MEAs
Phenotypic screening using MEAsPhenotypic screening using MEAs
Phenotypic screening using MEAs
 
NKCC1 Poster for SIRS 2010
NKCC1 Poster for SIRS 2010NKCC1 Poster for SIRS 2010
NKCC1 Poster for SIRS 2010
 
pòster-anglès-ok2
pòster-anglès-ok2pòster-anglès-ok2
pòster-anglès-ok2
 
Oxidative, Metabolic, and Fibril Stress in Alzheimer Disease
Oxidative, Metabolic, and Fibril Stress in Alzheimer DiseaseOxidative, Metabolic, and Fibril Stress in Alzheimer Disease
Oxidative, Metabolic, and Fibril Stress in Alzheimer Disease
 
Insights into the epigenetic mechanisms involving histone lysine
Insights into the epigenetic mechanisms involving histone lysineInsights into the epigenetic mechanisms involving histone lysine
Insights into the epigenetic mechanisms involving histone lysine
 
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
 
Monitoring neural activities by optical imaging
Monitoring neural activities by optical imagingMonitoring neural activities by optical imaging
Monitoring neural activities by optical imaging
 
Povlishock, John
Povlishock, JohnPovlishock, John
Povlishock, John
 
Mockabee COM scholar poster 032316
Mockabee COM scholar poster 032316Mockabee COM scholar poster 032316
Mockabee COM scholar poster 032316
 
Poster - determining the effects of tau on synaptic density in a mouse model ...
Poster - determining the effects of tau on synaptic density in a mouse model ...Poster - determining the effects of tau on synaptic density in a mouse model ...
Poster - determining the effects of tau on synaptic density in a mouse model ...
 
Florence Molinari INMED-INSERM U901. Marseille.
Florence Molinari   INMED-INSERM U901. Marseille. Florence Molinari   INMED-INSERM U901. Marseille.
Florence Molinari INMED-INSERM U901. Marseille.
 
Florence Molinari - INMED-INSERM U901. Marseille.
Florence Molinari - INMED-INSERM U901. Marseille. Florence Molinari - INMED-INSERM U901. Marseille.
Florence Molinari - INMED-INSERM U901. Marseille.
 
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) t...
 
Presentation at the CRS Mtg 2002
Presentation at the CRS Mtg 2002Presentation at the CRS Mtg 2002
Presentation at the CRS Mtg 2002
 
Imaginal discs1
Imaginal discs1Imaginal discs1
Imaginal discs1
 
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
Optical propagation of blue LED light in brain tissue and Parylene-C used in ...
 
Positron emission tomographic scan
Positron emission tomographic scanPositron emission tomographic scan
Positron emission tomographic scan
 
App ca1 paula
App ca1 paulaApp ca1 paula
App ca1 paula
 

DissertationPresentation

  • 1. Analysis of Cellular and Molecular Factors Influencing Axonal Degeneration in Neonatal Mice Alexis Doggett
  • 2. Background Purpose: Investigate cellular and molecular factors influencing axonal degeneration, rather than NMJ degeneration, in response to peripheral nerve injury in mice WHY? Neurodegenerative conditions affect millions of people world wide, and motor neuron degeneration as a widely observed symptom in a subset of these diseases, the cause of, which is still not fully understood. Any research done to investigate influences in these disease processes is critically important for finding cures. Part 1: Ex-vivo sciatic nerves from wild type mice over a period of 72 hours from ages P9-P22 Part II: Examining protein expression from three proteins implicated in neurodegenerative processes, in brachial plexus nerves from wild type mice ages P12- P24  ROCK2: neuronal survival and stability; actin regulator  Prp: cellular adhesion, synaptic metabolism, and signal transmission  SMN: mRNA splicing and axonal transport
  • 3. Aims and Hypotheses 1. Identify changes in axonal degeneration by quantifying levels of WD in neonatal and adult mice. 2. Identify differences in protein expression from ROCK2, Prp and SMN across the range in which age- dependent vulnerability shifts. 3. Discover whether there is a difference in rate of axonal degeneration between 2B/+ & 2B/- (SMN deficient) mouse models.
  • 4. Methods  Axonal Imagining ◦ Ex-Vivo model with Fluorescent Imaging ◦ Statistical Analysis  The Axonal Integrity Ratio (AIR) was calculated by dividing the sum total of fragmented lengths by the total length of the axon.  Protein Expression Quantification ◦ Western-Blot ◦ LiCOR Scanning
  • 5. What to look for: Part I  What is Wallerian Degeneration (WD)? ◦ Degeneration that appears along the axon as fragmentation or broken bits P14 Sciatic Axons at 21 Hours P14 Sciatic Axons at 72 Hours
  • 6. AIM1: Identify changes in axonal degeneration by quantifying levels of WD in neonatal and adult mice. P9 P14 P18 P22 P9 P14 P18 P22 0.0 0.2 0.4 0.6 0.8 Axonal Integrity at 72hrs ExVivo Age of YFP Wild Type Mice (Postnatal) AIR(AxonIntegrityRatio) * ns Comparison of AIR between neonatal and adult mice: (A) Fluorescent Microscopic images taken of P9, P14, P18, and P22 Scale Bar: 100μm (B) Average AIR quantifications from each time point (P9-P22) compared against each other, at 72 hours ex-vivo. Statistically significant difference in degeneration at 72-hours, between P9 and P22 axons (bars above data sets represent mean + SEM).
  • 7. What to look for: Part II  Changes in Protein Expression ◦ Sample intensity is greater (darker) with larger protein expression P12A 10μg 15μg 20μg 30μg SMN Expression P12B
  • 8. AIM 2: Identify differences in protein expression from ROCK2, Prp and SMN. P12 P15 P18 P21 P24 0.0 0.5 1.0 1.5 SMN Expression In Brachial Plexus Nerves of Wild Type Mice Age of Wild Type Mice (Postnatal) ProteinExpression P12 P15 P18 P21 P24 Figure 3.2.2. SMN Expression. This figure represents the mean with + SEM of SMN expression across all five sample ages. Data from this graph was quantified using an N=2, where P15-24 are normalized to the primary loading of P12. Due to the small N number the data yielded no statistical significance for any sample sets. A general trend can be seen where the SMN expression does decrease as age of mice increases. SMN α-Tub P12 P15 P18 P21 P24
  • 9. AIM 3: Discover whether there is a difference in rate of axonal degeneration between 2B/+ & 2B/- (SMN deficient) mouse models. P18 2B+ at 0 Hrs P18 2B- at 0 Hrs P18 2B+ at 72 Hrs P18 2B- at 72 Hrs (A) Fluorescent Microscopy images taken under a green fluorescent channel of P18 2B/+ and 2B/- Sciatic nerves following dissection and at 72-Hours ex-vivo. Images were taken at 20x magnification. Scale bar: 100μm. (B) Graph displays differences in AIR quantification between 2B/- (SMN deficient) and 2B/+ (Control) mouse models. Data was quantified using N=20 axons from 4 nerves of each phenotype. No significant difference noted in degeneration using a Mann-Whitney analysis, p-value = 0.1292 (bars above data sets represent mean + SEM). 2B - 2B + 0.0 0.2 0.4 0.6 0.8 Axonal Integrity of 2B- vs 2B+ mice at 72 hours Mouse Phenotype AIR(AxonIntegrityRatio) ns A B
  • 10. Conclusion  This project utilized an ex-vivo model to observe degeneration in neonatal and adult wild type sciatic nerves ◦ Proved that age-dependent vulnerability does exist in peripheral nerve axons, similar to that seen within the NMJ.  This project also explored potential molecular mechanisms influencing axonal degeneration ◦ Showed that ROCK2, Prp, and SMN protein expression all change as age increases. ◦ SMN displayed a trend of decreasing as age of mice increased  This project investigated whether levels of SMN expression effect rates of degeneration ◦ Found that SMN deficient models do not present with a statistically significant change in axonal degeneration compared to mice with normal SMN expression.
  • 11. Relevance and Future Studies  Better understanding of mechanisms that effect neurodegeneration.  Investigation into proteins and their exact influence on motor neurons can lead to potential treatments for patients suffering from disease.  Future Studies: ◦ Other disease models and axonal protection ◦ Other protein expression changes over time (i.e. ApoE, Htt, P-Tau)
  • 12. Thanks for Listening!  Any Question?